Avid Bioservices Inc (CDMO)

[swg_tdr]

CP, 100-200Bil$ market in cancer diagnostics, NOT as the overall worldwide cancer treatment cost is $100billion, see below

so current blood draw (basic as to client overall health and of drug saturation?) now minimal compared to a $80k to 120k annual patient billing for lung cancer treatment, if he/she survives so long. My recollection is $3k including a comprehensive components analysis.

LET US GUESS OUR EXOSOME MARKET SIZE, assuming speedy and simple (equals low cost) but also critical in assessing treatment response, so at say 4% of overall treatment costs should equals $5K max in USA, and at cost-plus might be a low $2k in EU, times ?patients? -- (stats, 14 million new cases world-wide, 7.3 million death). Plus general population screening in EU, at $200?

hence, the ultimate exo diagnostic pie could be $4B, to slice up between the hospitals, the supplier chains, the licencor and Peregrine with the kit manufacturing contractor.

but first this exosome test needs validation and market penetration -- and a guestimate of likely (or feasible rip-off high) billings. My guess the revenue the first three years might be low, or/and the potential is not recognized by Wall Street, as current PPS shows.

PS on our company site the exo technology pipeline is not shown yet (only the prior radio-isotope is)

interesting day, missed all, but thank you for your color on it.

best, N

Global Cancer Spending Reaches $100B | Data Mine | US News
https://www.usnews.com/news/blogs/data.../global-cancer-spending-reaches-100b

[PDF]Global Oncology Trend Report - Morning Consult
Cancer costs projected to reach at least $158 billion in 2020 | National ...
https://www.nih.gov/news.../cancer-costs-projected-reach-least-158-billion-2020

IMS Health Study: Global Market for Cancer Treatments Grows to $107 ...

Jan 23, 2017 - The financial costs of cancer are high for both the person with cancer and ... This year, about 600,920 Americans are expected to die of cancer ...
.
May 5, 2015 - Global spending on oncology treatments reached $100 billion last year, which ... Next How Marketing Exclusivity Led to Higher Drug Costs and ...
.